DJIA 17,050.75 138.46 0.82%
NASDAQ 4,810.79 19.64 0.41%
S&P 500 2,013.43 17.60 0.88%
market minute promo

Celgene (NASDAQ: CELG)

company name or ticker

Biotech bull market is dead

4 Top Jefferies Growth Stock Picks for Q4

Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?

Cancer immunotherapy is one of the hottest areas of cancer research these days, and the market looks to be worth billions. Which big pharma do we think will be the biggest winner in the space?

Stocks Slump on Fed, China, and Biotech Worries

Tough to Buy Stocks With More Declines Likely on the Way

Biotechs Battered: Comments On All Six Major Biotech Stocks

In Volatile Markets, Short Sellers Head For Biotechs

Clinton Proposals Could Spell Trouble for These 3 Drugmakers

An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.

Bezek's Daily Briefing: Biotech Struggles, Catalonia To Secede?

How the Top Biotechs Handled the Valuation Shock

See More Articles...